0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Livestock Animal Vaccines Market Research Report 2026
Published Date: 2026-02-13
|
Report Code: QYRE-Auto-8N9307
Home | Market Reports
Global Livestock Animal Vaccines Market Outlook 2022
BUY CHAPTERS

Global Livestock Animal Vaccines Market Research Report 2026

Code: QYRE-Auto-8N9307
Report
2026-02-13
Pages:129
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Livestock Animal Vaccines Market Size

The global Livestock Animal Vaccines market was valued at US$ 6094 million in 2025 and is anticipated to reach US$ 9052 million by 2032, at a CAGR of 5.9% from 2026 to 2032.

Livestock Animal Vaccines Market

Livestock Animal Vaccines Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Livestock Animal Vaccines competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Livestock animal vaccines are biological products designed to prevent and control infectious diseases in livestock and other economically important animals. By inducing specific immune responses, they help reduce disease incidence and mortality, ensuring the safety of livestock production and the stability of the food supply chain. This category includes inactivated, live-attenuated, recombinant, and subunit vaccines, offering protection against a wide range of pathogens, including viruses, bacteria, and parasites. The livestock animal vaccine industry serves as a cornerstone of the global animal health and biosecurity system, widely applied in cattle, swine, sheep, and poultry farming. With increasingly stringent disease prevention policies, accelerating livestock industrialization and scaling, and continuous advancements in biotechnology, livestock animal vaccines have become an indispensable strategic component of modern animal husbandry and public health systems.In 2024, global livestock animal vaccines production reached approximately 430 billion units , with an average global market price of around US$ 13.4 per k dose.
The global livestock animal vaccines market is driven by accelerating livestock industrialization and large-scale farming, making disease prevention and animal health management key competitive advantages. Rapid innovation in vaccine technology, particularly mRNA, recombinant protein, and nanoparticle delivery platforms, is enabling more precise, efficient, and traceable vaccine development. Governmental investment in agriculture and animal health policies, combined with heightened focus on food safety and public health, has further expanded vaccine adoption. Multinational animal health leaders and regional champions are intensifying R&D efforts, offering diversified vaccine portfolios covering multiple diseases and species, while the market evolves toward premiumization, specialization, and globalization.Despite its strong growth prospects, the industry faces multiple hurdles, including high R&D costs, lengthy regulatory approval processes, and complex global trade policies. The diversity and rapid mutation of animal pathogens demand timely and scientifically rigorous vaccine development and validation. Cold-chain infrastructure and storage requirements increase operational costs, particularly in emerging markets. Meanwhile, sudden regional disease outbreaks, trade barriers, and intense price competition challenge profitability. Companies must continuously invest in innovation, intellectual property protection, and supply chain optimization to maintain market resilience and product competitiveness.Demand for livestock animal vaccines is shifting from traditional disease prevention to high-value, precision health management solutions. Livestock producers and animal health organizations are adopting combination vaccines and customized immunization programs to enhance productivity and animal welfare. Rising consumer awareness of food safety and animal welfare is driving the industry toward disease-free production at the source, accelerating adoption of premium vaccines and innovative immunization technologies. Digital farm management and precision farming solutions are fostering deeper integration between the vaccine market and smart agriculture or IoT-enabled platforms.
Livestock animal vaccine production relies heavily on high-quality seed strains, cell lines, culture media, and adjuvant systems, all of which involve stringent regulatory standards and high technological barriers. The global upstream market is highly concentrated, with key components controlled by a small number of multinational suppliers and biotech specialists. Advances in biofermentation, serum-free culture, and nanotechnology have enabled localized sourcing of certain raw materials, offering more flexibility to vaccine manufacturers. However, traceability, quality consistency, and international certification of animal-derived raw materials remain top industry concerns, making supply chain security a core component of strategic planning.
This report delivers a comprehensive overview of the global Livestock Animal Vaccines market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Livestock Animal Vaccines. The Livestock Animal Vaccines market size, estimates, and forecasts are provided in terms of sales volume (M Dose) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Livestock Animal Vaccines market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Livestock Animal Vaccines manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Livestock Animal Vaccines Market Report

Report Metric Details
Report Name Livestock Animal Vaccines Market
Accounted market size in 2025 US$ 6094 million
Forecasted market size in 2032 US$ 9052 million
CAGR 5.9%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Live Attenuated Vaccine
  • Inactivated Vaccine
  • Other Vaccines
by Application
  • Pig
  • Cattle
  • Poultry
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merck, Boehringer Ingelheim, Zoetis, Ceva, Elanco, CAHIC, Jinyu Bio-Technology, HVRI, Ringpu Biology, Yebio, DHN, Kyoto Biken Laboratories, WINSUN, FATRO, CAVAC, MEVAC, Biovac, Cavet bio, Vaksindo, Bio-Labs
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Livestock Animal Vaccines manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Livestock Animal Vaccines sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Livestock Animal Vaccines Market growing?

Ans: The Livestock Animal Vaccines Market witnessing a CAGR of 5.9% during the forecast period 2026-2032.

What is the Livestock Animal Vaccines Market size in 2032?

Ans: The Livestock Animal Vaccines Market size in 2032 will be US$ 9052 million.

Who are the main players in the Livestock Animal Vaccines Market report?

Ans: The main players in the Livestock Animal Vaccines Market are Merck, Boehringer Ingelheim, Zoetis, Ceva, Elanco, CAHIC, Jinyu Bio-Technology, HVRI, Ringpu Biology, Yebio, DHN, Kyoto Biken Laboratories, WINSUN, FATRO, CAVAC, MEVAC, Biovac, Cavet bio, Vaksindo, Bio-Labs

What are the Application segmentation covered in the Livestock Animal Vaccines Market report?

Ans: The Applications covered in the Livestock Animal Vaccines Market report are Pig, Cattle, Poultry, Others

What are the Type segmentation covered in the Livestock Animal Vaccines Market report?

Ans: The Types covered in the Livestock Animal Vaccines Market report are Live Attenuated Vaccine, Inactivated Vaccine, Other Vaccines

1 Livestock Animal Vaccines Market Overview
1.1 Product Definition
1.2 Livestock Animal Vaccines by Type
1.2.1 Global Livestock Animal Vaccines Market Value by Type: 2025 vs 2032
1.2.2 Live Attenuated Vaccine
1.2.3 Inactivated Vaccine
1.2.4 Other Vaccines
1.3 Livestock Animal Vaccines by Application
1.3.1 Global Livestock Animal Vaccines Market Value by Application: 2025 vs 2032
1.3.2 Pig
1.3.3 Cattle
1.3.4 Poultry
1.3.5 Others
1.4 Global Livestock Animal Vaccines Market Size Estimates and Forecasts
1.4.1 Global Livestock Animal Vaccines Revenue 2021–2032
1.4.2 Global Livestock Animal Vaccines Sales 2021–2032
1.4.3 Global Livestock Animal Vaccines Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Livestock Animal Vaccines Market Competition by Manufacturers
2.1 Global Livestock Animal Vaccines Sales Market Share by Manufacturers (2021–2026)
2.2 Global Livestock Animal Vaccines Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Livestock Animal Vaccines Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Livestock Animal Vaccines, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Livestock Animal Vaccines, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Livestock Animal Vaccines, Product Types and Applications
2.7 Global Key Manufacturers of Livestock Animal Vaccines, Date of Entry into the Industry
2.8 Global Livestock Animal Vaccines Market Competitive Situation and Trends
2.8.1 Global Livestock Animal Vaccines Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Livestock Animal Vaccines Players Market Share by Revenue
2.8.3 Global Livestock Animal Vaccines Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Livestock Animal Vaccines Market Scenario by Region
3.1 Global Livestock Animal Vaccines Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Livestock Animal Vaccines Sales by Region: 2021–2032
3.2.1 Global Livestock Animal Vaccines Sales by Region: 2021–2026
3.2.2 Global Livestock Animal Vaccines Sales by Region: 2027–2032
3.3 Global Livestock Animal Vaccines Revenue by Region: 2021–2032
3.3.1 Global Livestock Animal Vaccines Revenue by Region: 2021–2026
3.3.2 Global Livestock Animal Vaccines Revenue by Region: 2027–2032
3.4 North America Livestock Animal Vaccines Market Facts & Figures by Country
3.4.1 North America Livestock Animal Vaccines Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Livestock Animal Vaccines Sales by Country (2021–2032)
3.4.3 North America Livestock Animal Vaccines Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Livestock Animal Vaccines Market Facts & Figures by Country
3.5.1 Europe Livestock Animal Vaccines Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Livestock Animal Vaccines Sales by Country (2021–2032)
3.5.3 Europe Livestock Animal Vaccines Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Livestock Animal Vaccines Market Facts & Figures by Region
3.6.1 Asia Pacific Livestock Animal Vaccines Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Livestock Animal Vaccines Sales by Region (2021–2032)
3.6.3 Asia Pacific Livestock Animal Vaccines Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Livestock Animal Vaccines Market Facts & Figures by Country
3.7.1 Latin America Livestock Animal Vaccines Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Livestock Animal Vaccines Sales by Country (2021–2032)
3.7.3 Latin America Livestock Animal Vaccines Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Livestock Animal Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Livestock Animal Vaccines Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Livestock Animal Vaccines Sales by Country (2021–2032)
3.8.3 Middle East and Africa Livestock Animal Vaccines Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Livestock Animal Vaccines Sales by Type (2021–2032)
4.1.1 Global Livestock Animal Vaccines Sales by Type (2021–2026)
4.1.2 Global Livestock Animal Vaccines Sales by Type (2027–2032)
4.1.3 Global Livestock Animal Vaccines Sales Market Share by Type (2021–2032)
4.2 Global Livestock Animal Vaccines Revenue by Type (2021–2032)
4.2.1 Global Livestock Animal Vaccines Revenue by Type (2021–2026)
4.2.2 Global Livestock Animal Vaccines Revenue by Type (2027–2032)
4.2.3 Global Livestock Animal Vaccines Revenue Market Share by Type (2021–2032)
4.3 Global Livestock Animal Vaccines Price by Type (2021–2032)
5 Segment by Application
5.1 Global Livestock Animal Vaccines Sales by Application (2021–2032)
5.1.1 Global Livestock Animal Vaccines Sales by Application (2021–2026)
5.1.2 Global Livestock Animal Vaccines Sales by Application (2027–2032)
5.1.3 Global Livestock Animal Vaccines Sales Market Share by Application (2021–2032)
5.2 Global Livestock Animal Vaccines Revenue by Application (2021–2032)
5.2.1 Global Livestock Animal Vaccines Revenue by Application (2021–2026)
5.2.2 Global Livestock Animal Vaccines Revenue by Application (2027–2032)
5.2.3 Global Livestock Animal Vaccines Revenue Market Share by Application (2021–2032)
5.3 Global Livestock Animal Vaccines Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Livestock Animal Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Merck Livestock Animal Vaccines Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Boehringer Ingelheim
6.2.1 Boehringer Ingelheim Company Information
6.2.2 Boehringer Ingelheim Description and Business Overview
6.2.3 Boehringer Ingelheim Livestock Animal Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Boehringer Ingelheim Livestock Animal Vaccines Product Portfolio
6.2.5 Boehringer Ingelheim Recent Developments/Updates
6.3 Zoetis
6.3.1 Zoetis Company Information
6.3.2 Zoetis Description and Business Overview
6.3.3 Zoetis Livestock Animal Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Zoetis Livestock Animal Vaccines Product Portfolio
6.3.5 Zoetis Recent Developments/Updates
6.4 Ceva
6.4.1 Ceva Company Information
6.4.2 Ceva Description and Business Overview
6.4.3 Ceva Livestock Animal Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Ceva Livestock Animal Vaccines Product Portfolio
6.4.5 Ceva Recent Developments/Updates
6.5 Elanco
6.5.1 Elanco Company Information
6.5.2 Elanco Description and Business Overview
6.5.3 Elanco Livestock Animal Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Elanco Livestock Animal Vaccines Product Portfolio
6.5.5 Elanco Recent Developments/Updates
6.6 CAHIC
6.6.1 CAHIC Company Information
6.6.2 CAHIC Description and Business Overview
6.6.3 CAHIC Livestock Animal Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 CAHIC Livestock Animal Vaccines Product Portfolio
6.6.5 CAHIC Recent Developments/Updates
6.7 Jinyu Bio-Technology
6.7.1 Jinyu Bio-Technology Company Information
6.7.2 Jinyu Bio-Technology Description and Business Overview
6.7.3 Jinyu Bio-Technology Livestock Animal Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Jinyu Bio-Technology Livestock Animal Vaccines Product Portfolio
6.7.5 Jinyu Bio-Technology Recent Developments/Updates
6.8 HVRI
6.8.1 HVRI Company Information
6.8.2 HVRI Description and Business Overview
6.8.3 HVRI Livestock Animal Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 HVRI Livestock Animal Vaccines Product Portfolio
6.8.5 HVRI Recent Developments/Updates
6.9 Ringpu Biology
6.9.1 Ringpu Biology Company Information
6.9.2 Ringpu Biology Description and Business Overview
6.9.3 Ringpu Biology Livestock Animal Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Ringpu Biology Livestock Animal Vaccines Product Portfolio
6.9.5 Ringpu Biology Recent Developments/Updates
6.10 Yebio
6.10.1 Yebio Company Information
6.10.2 Yebio Description and Business Overview
6.10.3 Yebio Livestock Animal Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Yebio Livestock Animal Vaccines Product Portfolio
6.10.5 Yebio Recent Developments/Updates
6.11 DHN
6.11.1 DHN Company Information
6.11.2 DHN Description and Business Overview
6.11.3 DHN Livestock Animal Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 DHN Livestock Animal Vaccines Product Portfolio
6.11.5 DHN Recent Developments/Updates
6.12 Kyoto Biken Laboratories
6.12.1 Kyoto Biken Laboratories Company Information
6.12.2 Kyoto Biken Laboratories Description and Business Overview
6.12.3 Kyoto Biken Laboratories Livestock Animal Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Kyoto Biken Laboratories Livestock Animal Vaccines Product Portfolio
6.12.5 Kyoto Biken Laboratories Recent Developments/Updates
6.13 WINSUN
6.13.1 WINSUN Company Information
6.13.2 WINSUN Description and Business Overview
6.13.3 WINSUN Livestock Animal Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 WINSUN Livestock Animal Vaccines Product Portfolio
6.13.5 WINSUN Recent Developments/Updates
6.14 FATRO
6.14.1 FATRO Company Information
6.14.2 FATRO Description and Business Overview
6.14.3 FATRO Livestock Animal Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 FATRO Livestock Animal Vaccines Product Portfolio
6.14.5 FATRO Recent Developments/Updates
6.15 CAVAC
6.15.1 CAVAC Company Information
6.15.2 CAVAC Description and Business Overview
6.15.3 CAVAC Livestock Animal Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 CAVAC Livestock Animal Vaccines Product Portfolio
6.15.5 CAVAC Recent Developments/Updates
6.16 MEVAC
6.16.1 MEVAC Company Information
6.16.2 MEVAC Description and Business Overview
6.16.3 MEVAC Livestock Animal Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 MEVAC Livestock Animal Vaccines Product Portfolio
6.16.5 MEVAC Recent Developments/Updates
6.17 Biovac
6.17.1 Biovac Company Information
6.17.2 Biovac Description and Business Overview
6.17.3 Biovac Livestock Animal Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Biovac Livestock Animal Vaccines Product Portfolio
6.17.5 Biovac Recent Developments/Updates
6.18 Cavet bio
6.18.1 Cavet bio Company Information
6.18.2 Cavet bio Description and Business Overview
6.18.3 Cavet bio Livestock Animal Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Cavet bio Livestock Animal Vaccines Product Portfolio
6.18.5 Cavet bio Recent Developments/Updates
6.19 Vaksindo
6.19.1 Vaksindo Company Information
6.19.2 Vaksindo Description and Business Overview
6.19.3 Vaksindo Livestock Animal Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Vaksindo Livestock Animal Vaccines Product Portfolio
6.19.5 Vaksindo Recent Developments/Updates
6.20 Bio-Labs
6.20.1 Bio-Labs Company Information
6.20.2 Bio-Labs Description and Business Overview
6.20.3 Bio-Labs Livestock Animal Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.20.4 Bio-Labs Livestock Animal Vaccines Product Portfolio
6.20.5 Bio-Labs Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Livestock Animal Vaccines Industry Chain Analysis
7.2 Livestock Animal Vaccines Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Livestock Animal Vaccines Production Mode & Process Analysis
7.4 Livestock Animal Vaccines Sales and Marketing
7.4.1 Livestock Animal Vaccines Sales Channels
7.4.2 Livestock Animal Vaccines Distributors
7.5 Livestock Animal Vaccines Customer Analysis
8 Livestock Animal Vaccines Market Dynamics
8.1 Livestock Animal Vaccines Industry Trends
8.2 Livestock Animal Vaccines Market Drivers
8.3 Livestock Animal Vaccines Market Challenges
8.4 Livestock Animal Vaccines Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Livestock Animal Vaccines Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Livestock Animal Vaccines Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Livestock Animal Vaccines Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Livestock Animal Vaccines Sales (M Dose) of Key Manufacturers (2021–2026)
 Table 5. Global Livestock Animal Vaccines Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Livestock Animal Vaccines Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Livestock Animal Vaccines Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Livestock Animal Vaccines Average Price (US$/Dose) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Livestock Animal Vaccines, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Livestock Animal Vaccines, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Livestock Animal Vaccines, Product Types and Applications
 Table 12. Global Key Manufacturers of Livestock Animal Vaccines, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Livestock Animal Vaccines Companies by Tier (Tier 1, Tier 2, Tier 3), based on Livestock Animal Vaccines Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Livestock Animal Vaccines Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Livestock Animal Vaccines Sales by Region (M Dose), 2021–2026
 Table 18. Global Livestock Animal Vaccines Sales Market Share by Region (2021–2026)
 Table 19. Global Livestock Animal Vaccines Sales by Region (M Dose), 2027–2032
 Table 20. Global Livestock Animal Vaccines Sales Market Share by Region (2027–2032)
 Table 21. Global Livestock Animal Vaccines Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Livestock Animal Vaccines Revenue Market Share by Region (2021–2026)
 Table 23. Global Livestock Animal Vaccines Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Livestock Animal Vaccines Revenue Market Share by Region (2027–2032)
 Table 25. North America Livestock Animal Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Livestock Animal Vaccines Sales by Country (M Dose), 2021–2026
 Table 27. North America Livestock Animal Vaccines Sales by Country (M Dose), 2027–2032
 Table 28. North America Livestock Animal Vaccines Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Livestock Animal Vaccines Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Livestock Animal Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Livestock Animal Vaccines Sales by Country (M Dose), 2021–2026
 Table 32. Europe Livestock Animal Vaccines Sales by Country (M Dose), 2027–2032
 Table 33. Europe Livestock Animal Vaccines Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Livestock Animal Vaccines Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Livestock Animal Vaccines Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Livestock Animal Vaccines Sales by Region (M Dose), 2021–2026
 Table 37. Asia Pacific Livestock Animal Vaccines Sales by Region (M Dose), 2027–2032
 Table 38. Asia Pacific Livestock Animal Vaccines Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Livestock Animal Vaccines Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Livestock Animal Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Livestock Animal Vaccines Sales by Country (M Dose), 2021–2026
 Table 42. Latin America Livestock Animal Vaccines Sales by Country (M Dose), 2027–2032
 Table 43. Latin America Livestock Animal Vaccines Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Livestock Animal Vaccines Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Livestock Animal Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Livestock Animal Vaccines Sales by Country (M Dose), 2021–2026
 Table 47. Middle East and Africa Livestock Animal Vaccines Sales by Country (M Dose), 2027–2032
 Table 48. Middle East and Africa Livestock Animal Vaccines Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Livestock Animal Vaccines Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Livestock Animal Vaccines Sales (M Dose) by Type (2021–2026)
 Table 51. Global Livestock Animal Vaccines Sales (M Dose) by Type (2027–2032)
 Table 52. Global Livestock Animal Vaccines Sales Market Share by Type (2021–2026)
 Table 53. Global Livestock Animal Vaccines Sales Market Share by Type (2027–2032)
 Table 54. Global Livestock Animal Vaccines Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Livestock Animal Vaccines Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Livestock Animal Vaccines Revenue Market Share by Type (2021–2026)
 Table 57. Global Livestock Animal Vaccines Revenue Market Share by Type (2027–2032)
 Table 58. Global Livestock Animal Vaccines Price (US$/Dose) by Type (2021–2026)
 Table 59. Global Livestock Animal Vaccines Price (US$/Dose) by Type (2027–2032)
 Table 60. Global Livestock Animal Vaccines Sales (M Dose) by Application (2021–2026)
 Table 61. Global Livestock Animal Vaccines Sales (M Dose) by Application (2027–2032)
 Table 62. Global Livestock Animal Vaccines Sales Market Share by Application (2021–2026)
 Table 63. Global Livestock Animal Vaccines Sales Market Share by Application (2027–2032)
 Table 64. Global Livestock Animal Vaccines Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Livestock Animal Vaccines Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Livestock Animal Vaccines Revenue Market Share by Application (2021–2026)
 Table 67. Global Livestock Animal Vaccines Revenue Market Share by Application (2027–2032)
 Table 68. Global Livestock Animal Vaccines Price (US$/Dose) by Application (2021–2026)
 Table 69. Global Livestock Animal Vaccines Price (US$/Dose) by Application (2027–2032)
 Table 70. Merck Company Information
 Table 71. Merck Description and Business Overview
 Table 72. Merck Livestock Animal Vaccines Sales (M Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 73. Merck Livestock Animal Vaccines Product
 Table 74. Merck Recent Developments/Updates
 Table 75. Boehringer Ingelheim Company Information
 Table 76. Boehringer Ingelheim Description and Business Overview
 Table 77. Boehringer Ingelheim Livestock Animal Vaccines Sales (M Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 78. Boehringer Ingelheim Livestock Animal Vaccines Product
 Table 79. Boehringer Ingelheim Recent Developments/Updates
 Table 80. Zoetis Company Information
 Table 81. Zoetis Description and Business Overview
 Table 82. Zoetis Livestock Animal Vaccines Sales (M Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 83. Zoetis Livestock Animal Vaccines Product
 Table 84. Zoetis Recent Developments/Updates
 Table 85. Ceva Company Information
 Table 86. Ceva Description and Business Overview
 Table 87. Ceva Livestock Animal Vaccines Sales (M Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 88. Ceva Livestock Animal Vaccines Product
 Table 89. Ceva Recent Developments/Updates
 Table 90. Elanco Company Information
 Table 91. Elanco Description and Business Overview
 Table 92. Elanco Livestock Animal Vaccines Sales (M Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 93. Elanco Livestock Animal Vaccines Product
 Table 94. Elanco Recent Developments/Updates
 Table 95. CAHIC Company Information
 Table 96. CAHIC Description and Business Overview
 Table 97. CAHIC Livestock Animal Vaccines Sales (M Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 98. CAHIC Livestock Animal Vaccines Product
 Table 99. CAHIC Recent Developments/Updates
 Table 100. Jinyu Bio-Technology Company Information
 Table 101. Jinyu Bio-Technology Description and Business Overview
 Table 102. Jinyu Bio-Technology Livestock Animal Vaccines Sales (M Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 103. Jinyu Bio-Technology Livestock Animal Vaccines Product
 Table 104. Jinyu Bio-Technology Recent Developments/Updates
 Table 105. HVRI Company Information
 Table 106. HVRI Description and Business Overview
 Table 107. HVRI Livestock Animal Vaccines Sales (M Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 108. HVRI Livestock Animal Vaccines Product
 Table 109. HVRI Recent Developments/Updates
 Table 110. Ringpu Biology Company Information
 Table 111. Ringpu Biology Description and Business Overview
 Table 112. Ringpu Biology Livestock Animal Vaccines Sales (M Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 113. Ringpu Biology Livestock Animal Vaccines Product
 Table 114. Ringpu Biology Recent Developments/Updates
 Table 115. Yebio Company Information
 Table 116. Yebio Description and Business Overview
 Table 117. Yebio Livestock Animal Vaccines Sales (M Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 118. Yebio Livestock Animal Vaccines Product
 Table 119. Yebio Recent Developments/Updates
 Table 120. DHN Company Information
 Table 121. DHN Description and Business Overview
 Table 122. DHN Livestock Animal Vaccines Sales (M Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 123. DHN Livestock Animal Vaccines Product
 Table 124. DHN Recent Developments/Updates
 Table 125. Kyoto Biken Laboratories Company Information
 Table 126. Kyoto Biken Laboratories Description and Business Overview
 Table 127. Kyoto Biken Laboratories Livestock Animal Vaccines Sales (M Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 128. Kyoto Biken Laboratories Livestock Animal Vaccines Product
 Table 129. Kyoto Biken Laboratories Recent Developments/Updates
 Table 130. WINSUN Company Information
 Table 131. WINSUN Description and Business Overview
 Table 132. WINSUN Livestock Animal Vaccines Sales (M Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 133. WINSUN Livestock Animal Vaccines Product
 Table 134. WINSUN Recent Developments/Updates
 Table 135. FATRO Company Information
 Table 136. FATRO Description and Business Overview
 Table 137. FATRO Livestock Animal Vaccines Sales (M Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 138. FATRO Livestock Animal Vaccines Product
 Table 139. FATRO Recent Developments/Updates
 Table 140. CAVAC Company Information
 Table 141. CAVAC Description and Business Overview
 Table 142. CAVAC Livestock Animal Vaccines Sales (M Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 143. CAVAC Livestock Animal Vaccines Product
 Table 144. CAVAC Recent Developments/Updates
 Table 145. MEVAC Company Information
 Table 146. MEVAC Description and Business Overview
 Table 147. MEVAC Livestock Animal Vaccines Sales (M Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 148. MEVAC Livestock Animal Vaccines Product
 Table 149. MEVAC Recent Developments/Updates
 Table 150. Biovac Company Information
 Table 151. Biovac Description and Business Overview
 Table 152. Biovac Livestock Animal Vaccines Sales (M Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 153. Biovac Livestock Animal Vaccines Product
 Table 154. Biovac Recent Developments/Updates
 Table 155. Cavet bio Company Information
 Table 156. Cavet bio Description and Business Overview
 Table 157. Cavet bio Livestock Animal Vaccines Sales (M Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 158. Cavet bio Livestock Animal Vaccines Product
 Table 159. Cavet bio Recent Developments/Updates
 Table 160. Vaksindo Company Information
 Table 161. Vaksindo Description and Business Overview
 Table 162. Vaksindo Livestock Animal Vaccines Sales (M Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 163. Vaksindo Livestock Animal Vaccines Product
 Table 164. Vaksindo Recent Developments/Updates
 Table 165. Bio-Labs Company Information
 Table 166. Bio-Labs Description and Business Overview
 Table 167. Bio-Labs Livestock Animal Vaccines Sales (M Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
 Table 168. Bio-Labs Livestock Animal Vaccines Product
 Table 169. Bio-Labs Recent Developments/Updates
 Table 170. Key Raw Materials Lists
 Table 171. Raw Materials Key Suppliers Lists
 Table 172. Livestock Animal Vaccines Distributors List
 Table 173. Livestock Animal Vaccines Customers List
 Table 174. Livestock Animal Vaccines Market Trends
 Table 175. Livestock Animal Vaccines Market Drivers
 Table 176. Livestock Animal Vaccines Market Challenges
 Table 177. Livestock Animal Vaccines Market Restraints
 Table 178. Research Programs/Design for This Report
 Table 179. Key Data Information from Secondary Sources
 Table 180. Key Data Information from Primary Sources
 Table 181. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Livestock Animal Vaccines
 Figure 2. Global Livestock Animal Vaccines Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Livestock Animal Vaccines Market Share by Type: 2025 & 2032
 Figure 4. Live Attenuated Vaccine Product Picture
 Figure 5. Inactivated Vaccine Product Picture
 Figure 6. Other Vaccines Product Picture
 Figure 7. Global Livestock Animal Vaccines Market Value by Application (US$ Million), 2021–2032
 Figure 8. Global Livestock Animal Vaccines Market Share by Application: 2025 & 2032
 Figure 9. Pig
 Figure 10. Cattle
 Figure 11. Poultry
 Figure 12. Others
 Figure 13. Global Livestock Animal Vaccines Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 14. Global Livestock Animal Vaccines Market Size (US$ Million), 2021–2032
 Figure 15. Global Livestock Animal Vaccines Sales (M Dose), 2021–2032
 Figure 16. Global Livestock Animal Vaccines Average Price (US$/Dose), 2021–2032
 Figure 17. Livestock Animal Vaccines Report Years Considered
 Figure 18. Livestock Animal Vaccines Sales Share by Manufacturers in 2025
 Figure 19. Global Livestock Animal Vaccines Revenue Share by Manufacturers in 2025
 Figure 20. Top 5 and Top 10 Global Livestock Animal Vaccines Players: Market Share by Revenue in Livestock Animal Vaccines in 2025
 Figure 21. Livestock Animal Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 22. Global Livestock Animal Vaccines Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 23. North America Livestock Animal Vaccines Sales Market Share by Country (2021–2032)
 Figure 24. North America Livestock Animal Vaccines Revenue Market Share by Country (2021–2032)
 Figure 25. U.S. Livestock Animal Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Canada Livestock Animal Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 27. Europe Livestock Animal Vaccines Sales Market Share by Country (2021–2032)
 Figure 28. Europe Livestock Animal Vaccines Revenue Market Share by Country (2021–2032)
 Figure 29. Germany Livestock Animal Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. France Livestock Animal Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. U.K. Livestock Animal Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Italy Livestock Animal Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Russia Livestock Animal Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Asia Pacific Livestock Animal Vaccines Sales Market Share by Region (2021–2032)
 Figure 35. Asia Pacific Livestock Animal Vaccines Revenue Market Share by Region (2021–2032)
 Figure 36. China Livestock Animal Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Japan Livestock Animal Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. South Korea Livestock Animal Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. India Livestock Animal Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Australia Livestock Animal Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Taiwan Livestock Animal Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Indonesia Livestock Animal Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Thailand Livestock Animal Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Malaysia Livestock Animal Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Philippines Livestock Animal Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Latin America Livestock Animal Vaccines Sales Market Share by Country (2021–2032)
 Figure 47. Latin America Livestock Animal Vaccines Revenue Market Share by Country (2021–2032)
 Figure 48. Mexico Livestock Animal Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Brazil Livestock Animal Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Argentina Livestock Animal Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Middle East and Africa Livestock Animal Vaccines Sales Market Share by Country (2021–2032)
 Figure 52. Middle East and Africa Livestock Animal Vaccines Revenue Market Share by Country (2021–2032)
 Figure 53. Turkey Livestock Animal Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Saudi Arabia Livestock Animal Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 55. UAE Livestock Animal Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 56. Global Sales Market Share of Livestock Animal Vaccines by Type (2021–2032)
 Figure 57. Global Revenue Market Share of Livestock Animal Vaccines by Type (2021–2032)
 Figure 58. Global Livestock Animal Vaccines Price (US$/Dose) by Type (2021–2032)
 Figure 59. Global Sales Market Share of Livestock Animal Vaccines by Application (2021–2032)
 Figure 60. Global Revenue Market Share of Livestock Animal Vaccines by Application (2021–2032)
 Figure 61. Global Livestock Animal Vaccines Price (US$/Dose) by Application (2021–2032)
 Figure 62. Livestock Animal Vaccines Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network